Skip to main content
. 2018 Jan 1;8(4):1121–1130. doi: 10.7150/thno.22601

Figure 4.

Figure 4

(A) Expression of GRPR in primary tumor and metastasis samples from patients with breast cancer (left). Correlation of SUVmean determined by 68Ga-BBN-RGD PET and GRPR expression level determined by immunohistochemical staining (r2 = 0.4791, P < 0.0001) (right). (B) Expression of integrin αvβ3 in primary tumor and metastasis samples from patients with breast cancer (left). Correlation of SUVmean determined by 68Ga-BBN-RGD PET and integrin αvβ3 expression level determined by immunohistochemical staining (r2 = 0.3664, P < 0.001) (right).